Literature DB >> 23652424

Isolated central hypothyroidism in young siblings as a manifestation of PROP1 deficiency: clinical impact of whole exome sequencing.

Ari J Wassner1, Laurie E Cohen, Eliana Hechter, Andrew Dauber.   

Abstract

BACKGROUND/AIMS: Central hypothyroidism (CH) in children is rare and may be due to a variety of genetic defects. Most of these defects, but not all, are associated with additional pituitary hormone deficits. In a young child presenting with CH, it is important to determine whether additional pituitary hormone deficiencies are present, but this may be difficult to establish clinically.
METHODS: We describe the clinical characteristics of two young siblings, aged 6 months and 2 years, presenting with isolated CH. Whole exome sequencing was performed to determine the genetic basis of isolated CH.
RESULTS: A homozygous frameshift mutation of PROP1 (296delGA) was identified in both probands. Defects in PROP1 cause progressive deficiency of multiple pituitary hormones. Based on this genetic diagnosis, further clinical testing was performed that demonstrated growth hormone deficiency in one sibling.
CONCLUSIONS: PROP1 deficiency may present as isolated CH at a very young age. In disorders with multiple potential causative genes, whole exome sequencing may facilitate rapid genetic diagnosis and lead to important changes in clinical management.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652424      PMCID: PMC3788832          DOI: 10.1159/000350013

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  36 in total

1.  Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene.

Authors:  F Pernasetti; S P Toledo; V V Vasilyev; C Y Hayashida; J D Cogan; C Ferrari; D M Lourenço; P L Mellon
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

2.  Plasma growth hormone responses and growth retardation of hypothyroidism.

Authors:  M H MacGillivray; T Aceto; L A Frohman
Journal:  Am J Dis Child       Date:  1968-02

3.  Hyperplastic pituitary gland, high serum glycoprotein hormone alpha-subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroidism due to mutations of the TSH beta gene.

Authors:  M Bonomi; M C Proverbio; G Weber; G Chiumello; P Beck-Peccoz; L Persani
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

4.  Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion.

Authors:  G Agarwal; V Bhatia; S Cook; P Q Thomas
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

5.  PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency.

Authors:  S Vallette-Kasic; A Barlier; C Teinturier; A Diaz; M Manavela; F Berthezène; P Bouchard; J L Chaussain; R Brauner; I Pellegrini-Bouiller; P Jaquet; A Enjalbert; T Brue
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

6.  Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure.

Authors:  R C Baxter; A S Brown; J R Turtle
Journal:  Clin Chem       Date:  1982-03       Impact factor: 8.327

7.  PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis.

Authors:  Antje Böttner; Eberhard Keller; Jürgen Kratzsch; Heike Stobbe; Johannes F W Weigel; Alexandra Keller; Wolfgang Hirsch; Wieland Kiess; Werner F Blum; Roland W Pfäffle
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

8.  Prolonged jaundice and hypothyroidism as the presenting symptoms in a neonate with a novel Prop1 gene mutation (Q83X).

Authors:  Antonis Voutetakis; Maria Maniati-Christidi; Christina Kanaka-Gantenbein; Maria Dracopoulou; Maria Argyropoulou; Sarantis Livadas; Catherine Dacou-Voutetakis; Amalia Sertedaki
Journal:  Eur J Endocrinol       Date:  2004-03       Impact factor: 6.664

9.  Screening for congenital hypothyroidism: results of screening one million North American infants.

Authors:  D A Fisher; J H Dussault; T P Foley; A H Klein; S LaFranchi; P R Larsen; M L Mitchell; W H Murphey; P G Walfish
Journal:  J Pediatr       Date:  1979-05       Impact factor: 4.406

10.  A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty.

Authors:  Armando Arroyo; Flavia Pernasetti; Vyacheslav V Vasilyev; Paula Amato; Samuel S C Yen; Pamela L Mellon
Journal:  Clin Endocrinol (Oxf)       Date:  2002-08       Impact factor: 3.478

View more
  4 in total

1.  The Pathogenic TSH β-subunit Variant C105Vfs114X Causes a Modified Signaling Profile at TSHR.

Authors:  Laura Kalveram; Gunnar Kleinau; Kamila Szymańska; Patrick Scheerer; Adolfo Rivero-Müller; Annette Grüters-Kieslich; Heike Biebermann
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

Review 2.  Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature.

Authors:  Hadley Stevens Smith; J Michael Swint; Seema R Lalani; Jose-Miguel Yamal; Marcia C de Oliveira Otto; Stephan Castellanos; Amy Taylor; Brendan H Lee; Heidi V Russell
Journal:  Genet Med       Date:  2018-05-14       Impact factor: 8.822

3.  Two coexisting heterozygous frameshift mutations in PROP1 are responsible for a different phenotype of combined pituitary hormone deficiency.

Authors:  K Ziemnicka; B Budny; K Drobnik; D Baszko-Błaszyk; M Stajgis; K Katulska; R Waśko; E Wrotkowska; R Słomski; M Ruchała
Journal:  J Appl Genet       Date:  2015-11-25       Impact factor: 3.240

4.  Whole Wiskott‑Aldrich syndrome protein gene deletion identified by high throughput sequencing.

Authors:  Xiangling He; Runying Zou; Bing Zhang; Yalan You; Yang Yang; Xin Tian
Journal:  Mol Med Rep       Date:  2017-08-31       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.